Poor Prognosis of COVID‐19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross‐Sectional Population Study Of 252 119 Patients

OBJECTIVE: Coronavirus disease 2019 (COVID‐19) has progressed rapidly around the world, reaching a lethality of up to 20% due to acute respiratory distress syndrome (ARDS). This latter condition is a relevant concern for systemic lupus erythematosus (SLE); however, data on this topic are limited to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoglio, Isabela Maria, Valim, Juliana Miranda de Lucena, Daffre, Danielle, Aikawa, Nádia Emi, Silva, Clovis Artur, Bonfá, Eloisa, Ugolini‐Lopes, Michelle Remião
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593786/
https://www.ncbi.nlm.nih.gov/pubmed/34423922
http://dx.doi.org/10.1002/acr2.11329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593786/
https://www.ncbi.nlm.nih.gov/pubmed/34423922
http://dx.doi.org/10.1002/acr2.11329

Ejemplares similares